ZyVersa Therapeutics Files Definitive Proxy Statement
Ticker: ZVSA · Form: DEF 14A · Filed: Apr 17, 2025 · CIK: 1859007
| Field | Detail |
|---|---|
| Company | Zyversa Therapeutics, Inc. (ZVSA) |
| Form Type | DEF 14A |
| Filed Date | Apr 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, disclosure, corporate-governance
Related Tickers: ZYVR
TL;DR
ZyVersa (ZYVR) filed its proxy statement. Standard shareholder disclosure.
AI Summary
ZyVersa Therapeutics, Inc. filed a definitive proxy statement (DEF 14A) on April 17, 2025. The filing concerns the company's proxy materials, indicating it is a standard disclosure for shareholders regarding company matters. ZyVersa Therapeutics, previously known as Larkspur Health Acquisition Corp. until April 26, 2021, is incorporated in Delaware and headquartered in Weston, Florida.
Why It Matters
This filing is a routine but important disclosure for shareholders, providing information about upcoming shareholder meetings and voting matters.
Risk Assessment
Risk Level: low — This is a routine proxy statement filing, not indicating any immediate financial or operational risks.
Key Players & Entities
- ZyVersa Therapeutics, Inc. (company) — Registrant
- Larkspur Health Acquisition Corp. (company) — Former company name
- 0001641172-25-005242.txt (document) — Filing document identifier
- 20250417 (date) — Filing date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used to solicit shareholder votes on important company matters, such as director elections or mergers, and provides detailed information about these proposals.
When was ZyVersa Therapeutics, Inc. formerly known as Larkspur Health Acquisition Corp.?
ZyVersa Therapeutics, Inc. was formerly known as Larkspur Health Acquisition Corp. until April 26, 2021.
What is the filing date of this DEF 14A statement?
This Definitive Proxy Statement was filed on April 17, 2025.
Where is ZyVersa Therapeutics, Inc. headquartered?
ZyVersa Therapeutics, Inc. is headquartered at 2200 N. Commerce Parkway, Suite 208, Weston, Florida 33326.
What is the Standard Industrial Classification (SIC) code for ZyVersa Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for ZyVersa Therapeutics, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 17, 2025 regarding ZyVersa Therapeutics, Inc. (ZVSA).